Kronos Bio KRON

$ 0.87 1.16%

Quarterly report 2024-Q3
added 11-13-2024

Kronos Bio Financial Statements 2011-2024 | KRON

Annual Financial Statements Kronos Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	69.3 M	84.9 M	744 M	1.49 B	-	-	-	-	-	-	-	-	-
Shares	57.7 M	56.2 M	54.8 M	54.2 M	-	-	-	-	-	-	-	-	-
Historical Prices	1.2	1.51	13.6	29.9	-	-	-	-	-	-	-	-	-
Net Income	-113 M	-133 M	-151 M	-88.4 M	-16.1 M	-6.72 M	-	-	-	-	-	-	-
Revenue	6.29 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-122 M	-137 M	-151 M	-58 M	-16.8 M	-6.64 M	-	-	-	-	-	-	-
Interest Expense	-	-	-	3.89 M	3 K	76 K	-	-	-	-	-	-	-
EBITDA	-120 M	-135 M	-149 M	-57.2 M	-16.5 M	-6.55 M	-	-	-	-	-	-	-
Operating Expenses	128 M	137 M	151 M	58 M	16.8 M	6.64 M	-	-	-	-	-	-	-
General and Administrative Expenses	41.7 M	43.4 M	38.5 M	14.8 M	3.37 M	1.61 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Kronos Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	60.3 M	60.1 M	59.5 M	58.9 M	58.1 M	57.4 M	57.1 M	57 M	56.3 M	56.1 M	55.8 M	55.7 M	55 M	54.5 M	54.2 M	16.3 M	6.13 M	5.83 M	5.69 M	5.28 M	5.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-14.1 M	-16.2 M	-30 M	-	-31.4 M	-29.7 M	-26.2 M	-	-32.3 M	-32.9 M	-36.3 M	-	-33.6 M	-29.1 M	-26.1 M	-88.4 M	-39.7 M	-8.58 M	-7 M	-16.1 M	-4.01 M	-3.51 M	-3.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	2.37 M	2.69 M	2.52 M	-	917 K	1.86 M	1.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-15.7 M	-18 M	-32 M	-	-33.8 M	-32.2 M	-28.5 M	-	-33.5 M	-33.5 M	-36.4 M	-	-33.7 M	-29.1 M	-26.2 M	-	-20.8 M	-8.8 M	-7.35 M	-	-4.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.89 M	-	1 K	-	1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-15.3 M	-17.6 M	-31.5 M	-	-33.3 M	-31.6 M	-27.9 M	-	-32.9 M	-32.9 M	-35.8 M	-	-33.2 M	-28.6 M	-25.7 M	800 K	-20.6 M	-8.7 M	-7.19 M	400 K	-4.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	18.1 M	20.7 M	34.5 M	-	34.7 M	34 M	29.7 M	-	33.5 M	33.5 M	36.4 M	-	33.7 M	29.1 M	26.2 M	-	20.8 M	8.8 M	7.35 M	-	4.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	5.82 M	6.37 M	7.51 M	-	9.4 M	10.3 M	10.1 M	-	10.1 M	10.8 M	11.9 M	-	8.98 M	9.34 M	8.58 M	-	4.05 M	1.62 M	1.15 M	-	797 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency